Literature DB >> 14513406

Persistent bacteremia in the absence of defined intravascular foci: clinical significance and risk factors.

M Y Chowers1, B Gottesman, M Paul, M Weinberger, S Pitlik, L Leibovici.   

Abstract

The clinical significance of and the risk factors for persistent bacteremia were assessed in 299 episodes. Persistent bacteremia was defined as at least two positive blood cultures obtained on different calendar days during the same infectious episode. Short-term bacteremia was defined as positive blood cultures solely on the first day of the infectious episode. A total of 4,277 episodes of bloodstream infections were detected, of which 299 episodes (7%) were persistent bacteremia. The following were independent risk factors were for persistent bacteremia: burns, presence of a central vascular catheter, cirrhosis, infections caused by Salmonella spp., polymicrobial infections, and inappropriate empirical antibiotic treatment. Irrespective of the source of infection, the presence of a central vascular catheter was correlated with an increased risk for persistent bacteremia. Mortality among patients with persistent bacteremia was 50%, compared to 35% among patients with short-term bacteremia. Because of the high mortality associated with persistent bacteremia, a thorough search for the source of infection is essential to ensure timely and appropriate therapy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14513406     DOI: 10.1007/s10096-003-0999-y

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  20 in total

Review 1.  Guidelines for the management of intravascular catheter-related infections.

Authors:  L A Mermel; B M Farr; R J Sherertz; I I Raad; N O'Grady; J S Harris; D E Craven
Journal:  Clin Infect Dis       Date:  2001-04-03       Impact factor: 9.079

Review 2.  Gut flora in health and disease.

Authors:  Francisco Guarner; Juan-R Malagelada
Journal:  Lancet       Date:  2003-02-08       Impact factor: 79.321

Review 3.  Source control in the management of sepsis.

Authors:  M F Jimenez; J C Marshall
Journal:  Intensive Care Med       Date:  2001       Impact factor: 17.440

4.  Blood cultures.

Authors:  M D Aronson; D H Bor
Journal:  Ann Intern Med       Date:  1987-02       Impact factor: 25.391

5.  Treatment and outcome of Staphylococcus aureus bacteremia: a prospective study of 278 cases.

Authors:  Allan G Jensen; Carsten H Wachmann; Frank Espersen; Jens Scheibel; Peter Skinhøj; Niels Frimodt-Møller
Journal:  Arch Intern Med       Date:  2002-01-14

Review 6.  Pathogenesis of catheter-related infections: lessons for new designs.

Authors:  A Pascual
Journal:  Clin Microbiol Infect       Date:  2002-05       Impact factor: 8.067

7.  Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial.

Authors:  D G Maki; S M Stolz; S Wheeler; L A Mermel
Journal:  Ann Intern Med       Date:  1997-08-15       Impact factor: 25.391

8.  Sporadic bacteremia complicating central venous catheter use in a community hospital: a model to predict frequency and aid in decision-making for initiation of investigation.

Authors:  N J Ehrenkranz; D G Eckert; P M Phillips
Journal:  Am J Infect Control       Date:  1989-04       Impact factor: 2.918

9.  The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection.

Authors:  L Leibovici; I Shraga; M Drucker; H Konigsberger; Z Samra; S D Pitlik
Journal:  J Intern Med       Date:  1998-11       Impact factor: 8.989

10.  Pathogenesis of catheter sepsis: a prospective study with quantitative and semiquantitative cultures of catheter hub and segments.

Authors:  J Liñares; A Sitges-Serra; J Garau; J L Pérez; R Martín
Journal:  J Clin Microbiol       Date:  1985-03       Impact factor: 5.948

View more
  1 in total

Review 1.  An alternate pathophysiologic paradigm of sepsis and septic shock: implications for optimizing antimicrobial therapy.

Authors:  Anand Kumar
Journal:  Virulence       Date:  2013-11-01       Impact factor: 5.882

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.